EP Patent

EP3856173A4 — TREATMENT OF HEMOPATHY MALIGNANCE WITH MENIN INHIBITORS

Assigned to Kura Oncology Inc · Expires 2022-07-06 · 4y expired

What this patent protects

Patent listed against Komzifti.

Drugs covered by this patent

Komzifti (ZIFTOMENIB) · Kura

Patent Metadata

Patent number: EP3856173A4
Jurisdiction: EP
Classification: —
Expires: 2022-07-06
Drug substance claim: No
Drug product claim: No
Assignee: Kura Oncology Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.